Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database.
Amandine GouverneurPauline ClarazMarine RoussetMickaël ArnaudAnnie Fourrier-RéglatAntoine ParienteThomas AparicioGhada Miremont-SalaméPernelle NoizePublished in: Targeted oncology (2018)
ADRs related to targeted therapies used for mCRC treatment were different across age groups; yet, not systematically more reported or worse in elderly patients. Selected elderly patients could, therefore, be treated with these targeted therapies.